← Eichor
Study identifier: NCT05479474 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Platelet Rich Plasma Testis Treatment for Infertile Men

Condition: Male Infertility · Nonobstructive Azoospermia · Azoospermia  ·  Sponsor: Stanford University

PhaseNA
Planned participants10
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Investigate the effect of intratesticular injection of autologous platelet rich plasma (PRP) on sperm retrieval rates and IVF outcomes in infertile men who already underwent a negative sperm retrieval. Currently, there is no alternative treatment after failed TESE. Prior series suggest that intratesticular PRP injections may improve TESE outcomes. We hope to determine whether PRP is an effective treatment for this patient population.

This description comes directly from the study's public registry record.

Talk to the study team

Satvir Basran  ·  650-723-0948  ·  sbasran@stanford.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Stanford Urology ClinicStanford, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05479474